Orange, France

Virginie Labe

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2018.


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Virginie Labe: Innovator in Radionuclide Treatment

Introduction

Virginie Labe is a notable inventor based in Orange, France. She has made significant contributions to the field of radionuclide treatment, particularly through her innovative methods. Her work focuses on improving the pre-calcining treatment of aqueous nitric solutions containing radionuclides.

Latest Patents

Virginie Labe holds a patent for a method that enhances the treatment of nitric aqueous solutions comprising at least one radionuclide and optionally ruthenium. The patent describes a process that involves adding a compound selected from lignins, lignocelluloses, and their salts or mixtures to the solution. This innovative approach aims to optimize the treatment before calcination, showcasing her expertise in the field.

Career Highlights

Virginie Labe is associated with the Commissariat à l'Énergie Atomique et aux Énergies Alternatives, a prominent research institution in France. Her work there has led to advancements in the treatment of hazardous materials, contributing to safer environmental practices.

Collaborations

She has collaborated with notable colleagues, including Frédéric Goettmann and Camille Carrignon. These partnerships have fostered a collaborative environment that enhances research and innovation in their field.

Conclusion

Virginie Labe's contributions to radionuclide treatment exemplify her commitment to innovation and safety in environmental practices. Her patent and collaborative efforts reflect her significant role in advancing this important area of research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…